Smartkarma's AI Co-Pilot, Smartkarma

αSK

Smartkarma's AI Co-Pilot

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>ALS is a global leader in the testing, inspection, and certification (TIC) industry, with a strategic focus on expanding its high-margin Life Sciences division to complement its historically dominant, but cyclical, Commodities business.</li>
  <li>The company has demonstrated strong top-line growth, with revenue increasing from A$2.28 billion in FY23 to A$3.00 billion in FY25, driven by both organic expansion and strategic acquisitions. However, statutory net profit has shown volatility, notably impacted in FY24 by a significant impairment charge related to its investment in Nuvisan.</li>
  <li>Forward strategy is centered on achieving mid-single-digit organic revenue growth, supported by disciplined M&amp;A and investments in technology and laboratory infrastructure to capitalize on favorable trends in environmental, pharmaceutical, and food testing.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  ALS is a global leader in the testing, inspection, and certification (TIC) industry, with a strategic focus on expanding its high-margin Life Sciences division to complement its historically dominant, but cyclical, Commodities business.
  The company has demonstrated strong top-line growth, with revenue increasing from A$2.28 billion in FY23 to A$3.00 billion in FY25, driven by both organic expansion and strategic acquisitions. However, statutory net profit has shown volatility, notably impacted in FY24 by a significant impairment charge related to its investment in Nuvisan.
  Forward strategy is centered on achieving mid-single-digit organic revenue growth, supported by disciplined M&amp;A and investments in technology and laboratory infrastructure to capitalize on favorable trends in environmental, pharmaceutical, and food testing.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Financial News, Analysis and Data, FNArena

FNArena

Financial News, Analysis and Data

Online financial media company focused on Australian equities, with a global perspective

<ul><li>Rising demand for commodities testing, supported by the soaring gold price, provided a strong first half for ALS Ltd, and it appears there&rsquo;s more to come.</li><li> -ALS Ltd first half beat expectations -Better than expected growth in minerals testing -Junior miners set to begin exploration, increasing demand -Guidance seen as conservative</li></ul>

Rising demand for commodities testing, supported by the soaring gold price, provided a strong first half for ALS Ltd, and it appears there&rsquo;s more to come. -ALS Ltd first half beat expectations -Better than expected growth in minerals testing -Junior miners set to begin exploration, increasing demand -Guidance seen as conservative

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<ul>
<li>We will stay near-term bullish as long as crucial support levels of 6780-6824 on SPX and $141.50 on ACWI-US continue to hold.</li>
<li>We are not fighting the bullish trend with all the MSCI global indexes (MSCI ACWI, EAFE, ACWI ex-US, and EM) hitting multi-year highs, but we are monitoring potential concerns</li>
<li>The bulk of new buy ideas that we see continue to be within commodity Sectors (Energy, Materials, with Materials highlighted today) and defensives (Health Care, Telecomm, and Services highlighted today)</li>
</ul>


We will stay near-term bullish as long as crucial support levels of 6780-6824 on SPX and $141.50 on ACWI-US continue to hold.
We are not fighting the bullish trend with all the MSCI global indexes (MSCI ACWI, EAFE, ACWI ex-US, and EM) hitting multi-year highs, but we are monitoring potential concerns
The bulk of new buy ideas that we see continue to be within commodity Sectors (Energy, Materials, with Materials highlighted today) and defensives (Health Care, Telecomm, and Services highlighted today)


Can Strength Continue for Korea, Taiwan, and EM?; Remain Overweight But Be Prepared for Volatility

Index Rebal/Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Index Rebal/Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

Index Rebalance

<ul>
<li>In this insight, we have presented our final expectations for index changes for ASX 200, 100, 50, and 20 for the June 2026 index rebal event.</li>
<li>Currently, we expect one regular change for ASX 50 and four regular changes for ASX 200 during the rebalance. Separately, there could be a couple of M&amp;A-related index changes too.</li>
<li>The index review results will be confirmed in early-June 2026.</li>
</ul>


In this insight, we have presented our final expectations for index changes for ASX 200, 100, 50, and 20 for the June 2026 index rebal event.
Currently, we expect one regular change for ASX 50 and four regular changes for ASX 200 during the rebalance. Separately, there could be a couple of M&amp;A-related index changes too.
The index review results will be confirmed in early-June 2026.


Quiddity Leaderboard ASX Jun26: Final Expectations; 14 Changes in June Including M&A-Related Changes

<ul>
<li>We are seeing snap-back rallies in the largest global economies -- notably the U.S. and Japan, and also Europe to a lesser extent. However...</li>
<li>We're expecting to see lower highs develop at prior breakdown levels at 2690-2700 on the TOPIX and 4884 on the EURO STOXX 50, which are significant resistance levels.</li>
<li>Watching SPX resistance at 5585, or possible test of YTD highs/marginal new high, all fitting with our ongoing belief (since July 25) that ACWI-US going through 1-to 4-month pullback/consolidation.</li>
</ul>


We are seeing snap-back rallies in the largest global economies -- notably the U.S. and Japan, and also Europe to a lesser extent. However...
We're expecting to see lower highs develop at prior breakdown levels at 2690-2700 on the TOPIX and 4884 on the EURO STOXX 50, which are significant resistance levels.
Watching SPX resistance at 5585, or possible test of YTD highs/marginal new high, all fitting with our ongoing belief (since July 25) that ACWI-US going through 1-to 4-month pullback/consolidation.


MSCI ACWI Consolidation Continues; Outlook Remains Neutral; Buys Across Defensives & Other Sectors

Australia

ALS Limited is a commercial services company with national and international operations. The Company's services include analytical and testing services, producing industrial and commercial chemical products, and hospitality, cleaning, and catering products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

ALS Ltd (ALQ AU)

Primer: ALS Ltd (ALQ AU) - Apr 2026

ALS is a global leader in the testing, inspection, and certification (TIC) industry, with a strategic focus on expanding its high-margin Life...

αSK

ALS Strikes Gold, With Upside Potential

Rising demand for commodities testing, supported by the soaring gold price, provided a strong first half for ALS Ltd, and it appears there’s more...

FNArena

Can Strength Continue for Korea, Taiwan, and EM?; Remain Overweight But Be Prepared for Volatility

Can Strength Continue for Korea $EWY, Taiwan $EWT, and EM $EEM?; Remain Overweight But Be Prepared for Volatility. Bulk of new buy ideas continue...

Vermilion Research

MSCI ACWI Consolidation Continues; Outlook Remains Neutral; Buys Across Defensives & Other Sectors

MSCI $ACWI Consolidation Continues; Outlook Remains Neutral; Snap-Back Rallies in Japan $Nikkei $TOPIX, U.S. $SPX, Europe $STOXX fits with our view...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Primer: ALS Ltd (ALQ AU) - Apr 2026

ALS is a global leader in the testing, inspection, and certification (TIC) industry, with a strategic focus on expanding its high-margin Life...

αSK

ALS Strikes Gold, With Upside Potential

Rising demand for commodities testing, supported by the soaring gold price, provided a strong first half for ALS Ltd, and it appears there’s more...

FNArena

Can Strength Continue for Korea, Taiwan, and EM?; Remain Overweight But Be Prepared for Volatility

Can Strength Continue for Korea $EWY, Taiwan $EWT, and EM $EEM?; Remain Overweight But Be Prepared for Volatility. Bulk of new buy ideas continue...

Vermilion Research

Quiddity Leaderboard ASX Jun26: Final Expectations; 14 Changes in June Including M&A-Related Changes

We expect a total of 14 index changes in June 2026 including M&A-related index changes. Most of the index changes have decent impact and flow size.

Janaghan Jeyakumar, CFA

MSCI ACWI Consolidation Continues; Outlook Remains Neutral; Buys Across Defensives & Other Sectors

MSCI $ACWI Consolidation Continues; Outlook Remains Neutral; Snap-Back Rallies in Japan $Nikkei $TOPIX, U.S. $SPX, Europe $STOXX fits with our view...

Vermilion Research